COFIBCOL 4.500.000 IU IM/IV LYOPHILIZED POWDER AND SOLVENT FOR THE PREPARATION OF INJECTION AND INHALATION SOLUTION, 1 VIAL CONTAINING LYOPHILIZED POWDER + 1 AMPOULE CONTAINING SOLVENT
Turkey·Pharmaceutical Product·DEVA HOLDİNG A.Ş.·Licensed May 15, 2022- Product ID (UID)
- a73b55a892d20721fd1dee55dc716919
- License Number
- 2022/248
- Barcode
- 8699525798510
- ATC Code
- J01XB01
- License Holder
- DEVA HOLDİNG A.Ş.
- Active Ingredient (EN)
- Colistimemedate sodium
- License Date
- May 15, 2022
Access comprehensive regulatory information for COFIBCOL 4.500.000 IU IM/IV LYOPHILIZED POWDER AND SOLVENT FOR THE PREPARATION OF INJECTION AND INHALATION SOLUTION, 1 VIAL CONTAINING LYOPHILIZED POWDER + 1 AMPOULE CONTAINING SOLVENT in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number a73b55a892d20721fd1dee55dc716919 with license number 2022/248and contains active ingredient Colistimemedate sodium. The license is held by DEVA HOLDİNG A.Ş..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.